Compare Baroda BNP Paribas Health and Wellness Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.78
2.09
NAV
₹10.70
₹47.06
Fund Started
09 Jun 2025
25 Jun 2018
Fund Size
₹553.17 Cr
₹6624.58 Cr
Exit Load
Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Exit load of 1% if redeemed within 15 days.
1 Year
3.76%
6.41%
3 Year
-
24.51%
5 Year
-
15.50%
Equity
98.03%
96.05%
Cash
-0.58%
3.95%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 7.58% |
Lupin Ltd. | 6.56% |
Laurus Labs Ltd. | 6.31% |
Ipca Laboratories Ltd. | 5.80% |
Torrent Pharmaceuticals Ltd. | 5.43% |
Divi's Laboratories Ltd. | 5.35% |
Apollo Hospitals Enterprise Ltd. | 4.87% |
JB Chemicals & Pharmaceuticals Ltd. | 4.57% |
Fortis Healthcare Ltd. | 4.32% |
Astrazeneca Pharma India Ltd. | 3.87% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
09 Jun 2025
25 Jun 2018
